| Deler fremragende | 60,831,656 shares |
| Insideraktier | 17.707.083 shares |
| Insider ejerskab | 29,11 % |
| Total Insiders | 34 |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Insiderhandelsdiagram
Janux Therapeutics, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
|
Avalon BioVentures SPV I, L.P.
10% Owner -
|
4.479.492 | 2.115.373 | |
|
Avalon Ventures XI, L.P.
10% Owner -
|
2.115.373 | 2.115.373 | |
| Ronald W Barrett Director - [D] | 6.250 | 6.250 | |
|
Corp Bregua
10% Owner -
|
3.749.250 | 3.749.250 | |
| Vickie L Capps Director - [D] | 74.098 | 74.098 | |
| David Alan Campbell President and CEO, Director - [D] [O] | 381.582 | 381.582 | |
| Eric Dobmeier Director - [D] | 9.981 | 9.981 | |
| Thomas DiRaimondo Chief Scientific Officer - [O] | 155.825 | 155.825 | |
| Maria Dobek Vice President, Accounting - [O] | 34.308 | 34.308 | |
| Janeen Noel Doyle Chief Corp. & Bus. Dev. Ofcr - [O] | 80.000 | 80.000 | |
| William Go Chief Medical Officer - [O] | 44.000 | 44.000 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| Wayne Godfrey | 114.250 | ||
| Sheila Gujrathi Director - [D] | 118.889 | 118.889 | |
| Stefan Heller Director - [D] | 96.075 | 96.075 | |
| Natasha Hernday Director - [D] | 8.731 | 8.731 | |
|
Peter Kolchinsky
Director, 10% Owner -
[D]
|
1.048.406 | 6.250 | |
| Winston Kung Director - [D] | 6.250 | 6.250 | |
|
Jay Lichter
10% Owner -
|
6.560.816 | 6.560.816 | |
| Zachariah McIver Chief Medical Officer - [O] | 52.286 | 52.286 | |
| McNulty Alana B. Director - [D] | 6.250 | 6.250 | |
| Andrew Hollman Meyer Chief Business Officer - [O] | 83.095 | 83.095 | |
| Orbimed Advisors Llc Director - [D] | 231.098 | 231.098 |
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|---|---|---|
| OrbiMed Capital GP VII LLC Director - [D] | 245.898 | 245.898 | |
| OrbiMed Capital GP VIII LLC Director - [D] | 231.098 | 231.098 | |
| OrbiMed Genesis GP LLC Director - [D] | 231.098 | 231.098 | |
|
Ra Capital Management, Llc
Director, 10% Owner -
[D]
|
6.250 | 6.250 | |
|
RA Capital Healthcare Fund LP
Director, 10% Owner -
[D]
|
1.048.406 | 6.250 | |
| Tighe Reardon Acting Chief Financial Officer - [O] | 3.515.007 | 3.515.007 | |
| Byron Robinson Chief Strategy Officer - [O] | 28.000 | 28.000 | |
| Shahram Salek-Ardakani | 114.250 | ||
|
Shah Rajeev M.
Director, 10% Owner -
[D]
|
1.048.406 | 6.250 | |
| Jake Simson Director - [D] | 6.250 | 6.250 | |
| Thompson Peter A. Director - [D] | 231.098 | 231.098 | |
| Winter Charles M. Chief Technical Officer - [O] | 106.321 | 106.321 |
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i JANX / Janux Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i JANX / Janux Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-04 | 2026-02-02 | 4 | Go William | JANX | Common Stock | D | 44.000 | 44.000 | ||||||
| 2026-01-02 | 2026-01-02 | 4 | Winter Charles M. | JANX | Common Stock | D | 28.600 | 106.321 | ||||||
| 2026-01-02 | 2026-01-02 | 4 | Winter Charles M. | JANX | Common Stock | D | 13,7300 | -2.401 | -33 | 77.721 | ||||
| 2026-01-02 | 2026-01-02 | 4 | Campbell David Alan | JANX | Common Stock | D | 96.600 | 381.582 | ||||||
| 2026-01-02 | 2026-01-02 | 4 | Campbell David Alan | JANX | Common Stock | D | 13,7300 | -8.072 | -111 | 284.982 | ||||
| 2026-01-02 | 2026-01-02 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 13,7300 | -1.879 | -26 | 83.095 | ||||
| 2026-01-02 | 2026-01-02 | 4 | DiRaimondo Thomas | JANX | Common Stock | D | 31.400 | 155.825 | ||||||
| 2026-01-02 | 2026-01-02 | 4 | DiRaimondo Thomas | JANX | Common Stock | D | 13,7300 | -2.505 | -34 | 124.425 | ||||
| 2026-01-02 | 2026-01-02 | 4 | Doyle Janeen Noel | JANX | Common Stock | D | 36.000 | 80.000 | ||||||
| 2026-01-02 | 2026-01-02 | 4 | Dobek Maria | JANX | Common Stock | D | 18.935 | 34.308 | ||||||
| 2026-01-02 | 2026-01-02 | 4 | Dobek Maria | JANX | Common Stock | D | 13,7300 | -1.462 | -20 | 15.373 | ||||
| 2026-01-02 | 2026-01-02 | 4 | McIver Zachariah | JANX | Common Stock | D | 29.000 | 52.286 | ||||||
| 2026-01-02 | 2026-01-02 | 4 | McIver Zachariah | JANX | Common Stock | D | 13,7300 | -2.714 | -37 | 23.286 | ||||
| 2025-12-03 | 2025-12-01 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 33,5247 | -633 | -21 | 84.974 | ||||
| 2025-12-03 | 2025-12-01 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 32,8548 | -2.700 | -89 | 85.607 | ||||
| 2025-12-03 | 2025-12-01 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 10,5900 | 3.333 | 35 | 88.307 | ||||
| 2025-11-14 | 2025-11-14 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 30,0000 | -3.333 | -100 | 84.974 | ||||
| 2025-11-14 | 2025-11-14 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 10,5900 | 3.333 | 35 | 88.307 | ||||
| 2025-10-30 | 2025-10-28 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 30,0622 | -16.665 | -501 | 82.139 | ||||
| 2025-10-30 | 2025-10-28 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 10,5900 | 6.666 | 71 | 98.804 | ||||
| 2025-10-30 | 2025-10-28 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 4,2100 | 9.999 | 42 | 92.138 | ||||
| 2025-06-13 | 2025-06-11 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Common Stock | I | 3.750 | 6.250 | ||||||
| 2025-06-13 | 2025-06-11 | 4 | McNulty Alana B. | JANX | Common Stock | D | 3.750 | 6.250 | ||||||
| 2025-06-13 | 2025-06-11 | 4 | Hernday Natasha | JANX | Common Stock | D | 3.750 | 8.731 | ||||||
| 2025-06-13 | 2025-06-11 | 4 | Gujrathi Sheila | JANX | Common Stock | D | 3.750 | 118.889 | ||||||
| 2025-06-13 | 2025-06-11 | 4 | DOBMEIER ERIC | JANX | Common Stock | D | 3.750 | 9.981 | ||||||
| 2025-06-13 | 2025-06-11 | 4 | CAPPS VICKIE L | JANX | Common Stock | D | 3.750 | 74.098 | ||||||
| 2025-06-13 | 2025-06-11 | 4 | Barrett Ronald W | JANX | Common Stock | D | 3.750 | 6.250 | ||||||
| 2025-06-13 | 2025-06-11 | 4 | Kung Winston | JANX | Common Stock | D | 3.750 | 6.250 | ||||||
| 2025-06-13 | 2025-06-11 | 4 | Simson Jake | JANX | Common Stock | D | 3.750 | 6.250 | ||||||
| 2025-06-04 | 2025-06-02 | 4 | Doyle Janeen Noel | JANX | Common Stock | D | 44.000 | 44.000 | ||||||
| 2025-05-02 | 2025-05-01 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 32,6034 | -400 | -13 | 82.139 | ||||
| 2025-05-02 | 2025-05-01 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 31,9479 | -2.933 | -94 | 82.539 | ||||
| 2025-05-02 | 2025-05-01 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 4,2100 | 3.333 | 14 | 85.472 | ||||
| 2025-04-23 | 2025-04-21 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 30,0000 | -3.334 | -100 | 82.139 | ||||
| 2025-04-23 | 2025-04-21 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 4,2100 | 3.334 | 14 | 85.473 | ||||
| 2025-03-07 | 2025-03-07 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Common Stock | I | 31,0200 | 110.206 | 3.419 | 10.141.287 | ||||
| 2025-03-07 | 2025-03-06 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Common Stock | I | 30,7800 | 372.093 | 11.453 | 10.031.081 | ||||
| 2025-03-07 | 2025-03-05 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Common Stock | I | 31,3000 | 37.455 | 1.172 | 9.658.988 | ||||
| 2025-03-07 | 2025-03-05 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Common Stock | I | 30,5600 | 304.287 | 9.299 | 9.621.533 | ||||
| 2025-03-05 | 2025-03-03 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 32,8509 | -901 | -30 | 82.139 | ||||
| 2025-03-05 | 2025-03-03 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 31,8848 | -2.433 | -78 | 83.040 | ||||
| 2025-03-05 | 2025-03-03 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 4,2100 | 3.334 | 14 | 85.473 | ||||
| 2025-02-05 | 2025-02-03 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 43,6000 | -100 | -4 | 82.139 | ||||
| 2025-02-05 | 2025-02-03 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 42,7703 | -816 | -35 | 82.239 | ||||
| 2025-02-05 | 2025-02-03 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 42,0756 | -2.418 | -102 | 83.055 | ||||
| 2025-02-05 | 2025-02-03 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 4,2100 | 3.334 | 14 | 85.473 | ||||
| 2025-01-08 | 2025-01-07 | 4 | Campbell David Alan | JANX | Common Stock | D | 60,0008 | -5.000 | -300 | 293.054 | ||||
| 2025-01-03 | 2025-01-02 | 4 | Campbell David Alan | JANX | Common Stock | D | 81.000 | 298.054 | ||||||
| 2025-01-03 | 2025-01-02 | 4 | Robinson Byron | JANX | Common Stock | D | 28.000 | 28.000 | ||||||
| 2025-01-03 | 2025-01-02 | 4 | Dobek Maria | JANX | Common Stock | D | 14.000 | 14.001 | ||||||
| 2025-01-03 | 2025-01-02 | 4 | DiRaimondo Thomas | JANX | Common Stock | D | 24.000 | 129.719 | ||||||
| 2025-01-03 | 2025-01-02 | 4 | Winter Charles M. | JANX | Common Stock | D | 23.000 | 77.288 | ||||||
| 2025-01-03 | 2025-01-02 | 4 | McIver Zachariah | JANX | Common Stock | D | 26.000 | 26.000 | ||||||
| 2025-01-03 | 3/A | Winter Charles M. | JANX | Common Stock | D | 46.111 | ||||||||
| 2025-01-03 | 2025-01-02 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 57,3650 | -200 | -11 | 82.139 | ||||
| 2025-01-03 | 2025-01-02 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 56,7778 | -1.000 | -57 | 82.339 | ||||
| 2025-01-03 | 2025-01-02 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 55,7587 | -3.444 | -192 | 83.339 | ||||
| 2025-01-03 | 2025-01-02 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 54,5111 | -5.768 | -314 | 86.783 | ||||
| 2025-01-03 | 2025-01-02 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 53,7582 | -2.922 | -157 | 92.551 | ||||
| 2025-01-03 | 2025-01-02 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 18.000 | 95.473 | ||||||
| 2024-12-27 | 2024-12-24 | 4 | Campbell David Alan | JANX | Common Stock | D | 56,1922 | -25.000 | -1.405 | 217.054 | ||||
| 2024-12-20 | 2024-12-19 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 14,0200 | 1 | 0 | 77.473 | ||||
| 2024-12-20 | 2024-12-19 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 20,2400 | 9.880 | 200 | 77.472 | ||||
| 2024-12-03 | 2024-12-03 | 4 | Campbell David Alan | JANX | Common Stock | D | 67,0000 | -15.000 | -1.005 | 242.054 | ||||
| 2024-11-27 | 2024-11-25 | 4 | Campbell David Alan | JANX | Common Stock | D | 52,0385 | -6.719 | -350 | 257.054 | ||||
| 2024-11-27 | 2024-11-25 | 4 | Campbell David Alan | JANX | Common Stock | D | 51,4322 | -18.281 | -940 | 263.773 | ||||
| 2024-11-07 | 2024-11-05 | 4 | Gujrathi Sheila | JANX | Common Stock | D | 4.611 | 115.139 | ||||||
| 2024-11-07 | 2024-11-05 | 4 | CAPPS VICKIE L | JANX | Common Stock | D | 2.305 | 70.348 | ||||||
| 2024-10-30 | 2024-10-28 | 4 | Campbell David Alan | JANX | Common Stock | D | 53,9412 | -11.103 | -599 | 282.054 | ||||
| 2024-10-30 | 2024-10-28 | 4 | Campbell David Alan | JANX | Common Stock | D | 53,2237 | -13.897 | -740 | 293.157 | ||||
| 2024-10-24 | 2024-09-13 | 4 | Lichter Jay | JANX | Common Stock | D | 46,6800 | -3.815 | -178 | 7.000 | ||||
| 2024-10-24 | 2024-09-13 | 4 | Lichter Jay | JANX | Common Stock | D | 39,8000 | 391 | 16 | 10.815 | ||||
| 2024-10-24 | 2024-09-13 | 4 | Lichter Jay | JANX | Common Stock | D | 13,2200 | 778 | 10 | 10.424 | ||||
| 2024-10-24 | 2024-09-13 | 4 | Lichter Jay | JANX | Common Stock | D | 10,7300 | 778 | 8 | 9.646 | ||||
| 2024-10-24 | 2024-09-13 | 4 | Lichter Jay | JANX | Common Stock | D | 17,0000 | 1.868 | 32 | 8.868 | ||||
| 2024-10-22 | 2024-10-18 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Common Stock | I | 44,7500 | 1.200.000 | 53.700 | 9.317.246 | ||||
| 2024-10-18 | 2024-10-18 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures SPV I, L.P. | JANX | Common Stock | I | 44,7500 | -553.219 | -24.757 | 2.115.373 | ||||
| 2024-10-18 | 2024-10-18 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures I, LP | JANX | Common Stock | I | 44,7500 | -104.957 | -4.697 | 401.321 | ||||
| 2024-10-18 | 2024-10-18 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 44,7500 | -541.824 | -24.247 | 2.071.799 | ||||
| 2024-10-18 | 2024-10-18 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures SPV I, L.P. | JANX | Common Stock | I | 51,1800 | -15.788 | -808 | 2.668.592 | ||||
| 2024-10-18 | 2024-10-18 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures I, LP | JANX | Common Stock | I | 51,1800 | -2.995 | -153 | 506.278 | ||||
| 2024-10-18 | 2024-10-18 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 51,1800 | -15.462 | -791 | 2.613.623 | ||||
| 2024-10-18 | 2024-10-18 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures SPV I, L.P. | JANX | Common Stock | I | 50,3000 | -104.892 | -5.276 | 2.684.380 | ||||
| 2024-10-18 | 2024-10-18 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures I, LP | JANX | Common Stock | I | 50,3000 | -19.900 | -1.001 | 509.273 | ||||
| 2024-10-18 | 2024-10-18 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 50,3000 | -102.732 | -5.167 | 2.629.085 | ||||
| 2024-10-18 | 2024-10-17 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 50,0200 | -1.843 | -92 | 6.371 | ||||
| 2024-10-18 | 2024-10-17 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 39,8000 | 237 | 9 | 8.214 | ||||
| 2024-10-18 | 2024-10-17 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 13,2200 | 348 | 5 | 7.977 | ||||
| 2024-10-18 | 2024-10-17 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 10,7300 | 348 | 4 | 7.629 | ||||
| 2024-10-18 | 2024-10-17 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 17,0000 | 836 | 14 | 7.281 | ||||
| 2024-10-18 | 2024-10-16 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 50,8000 | -10.957 | -557 | 6.445 | ||||
| 2024-10-18 | 2024-10-16 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 39,8000 | 1.407 | 56 | 17.402 | ||||
| 2024-10-18 | 2024-10-16 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 13,2200 | 2.070 | 27 | 15.995 | ||||
| 2024-10-18 | 2024-10-16 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 10,7300 | 2.070 | 22 | 13.925 | ||||
| 2024-10-18 | 2024-10-16 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 17,0000 | 4.968 | 84 | 11.855 | ||||
| 2024-10-18 | 2024-10-16 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures SPV I, LP | JANX | Common Stock | I | 50,6100 | -30.094 | -1.523 | 2.789.272 | ||||
| 2024-10-18 | 2024-10-16 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures I, LP | JANX | Common Stock | I | 50,6100 | -5.710 | -289 | 529.173 | ||||
| 2024-10-18 | 2024-10-16 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 50,6100 | -29.474 | -1.492 | 2.731.817 | ||||
| 2024-10-18 | 2024-10-16 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures SPV I, L.P. | JANX | Common Stock | I | 49,6900 | -61.445 | -3.053 | 2.819.366 | ||||
| 2024-10-18 | 2024-10-16 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures I, LP | JANX | Common Stock | I | 49,6900 | -11.657 | -579 | 534.883 | ||||
| 2024-10-18 | 2024-10-16 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 49,6900 | -60.179 | -2.990 | 2.761.291 | ||||
| 2024-09-30 | 2024-09-30 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 46,2400 | -958 | -44 | 6.887 | ||||
| 2024-09-30 | 2024-09-30 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 39,8000 | 123 | 5 | 7.845 | ||||
| 2024-09-30 | 2024-09-30 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 13,2200 | 181 | 2 | 7.722 | ||||
| 2024-09-30 | 2024-09-30 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 10,7300 | 181 | 2 | 7.541 | ||||
| 2024-09-30 | 2024-09-30 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 17,0000 | 434 | 7 | 7.360 | ||||
| 2024-09-30 | 2024-09-27 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 46,1900 | -1.826 | -84 | 6.926 | ||||
| 2024-09-30 | 2024-09-27 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 39,8000 | 234 | 9 | 8.752 | ||||
| 2024-09-30 | 2024-09-27 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 13,2200 | 345 | 5 | 8.518 | ||||
| 2024-09-30 | 2024-09-27 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 10,7300 | 345 | 4 | 8.173 | ||||
| 2024-09-30 | 2024-09-27 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 17,0000 | 828 | 14 | 7.828 | ||||
| 2024-09-30 | 2024-09-27 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures SPV I, L.P. | JANX | Common Stock | I | 47,7400 | -1.542 | -74 | 2.880.811 | ||||
| 2024-09-30 | 2024-09-27 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures I, LP | JANX | Common Stock | I | 47,7400 | -293 | -14 | 546.540 | ||||
| 2024-09-30 | 2024-09-27 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 47,7400 | -1.511 | -72 | 2.821.470 | ||||
| 2024-09-30 | 2024-09-27 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures SPV I, L.P. | JANX | Common Stock | I | 46,4200 | -46.861 | -2.175 | 2.882.353 | ||||
| 2024-09-30 | 2024-09-27 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures I, LP | JANX | Common Stock | I | 46,4200 | -8.894 | -413 | 546.833 | ||||
| 2024-09-30 | 2024-09-27 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 46,4200 | -45.894 | -2.130 | 2.822.981 | ||||
| 2024-09-30 | 2024-09-26 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures SPV I, LP | JANX | Common Stock | I | 47,7700 | -41.661 | -1.990 | 2.929.214 | ||||
| 2024-09-30 | 2024-09-26 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures I, LP | JANX | Common Stock | I | 47,7700 | -7.908 | -378 | 555.727 | ||||
| 2024-09-30 | 2024-09-26 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 47,7700 | -40.803 | -1.949 | 2.868.875 | ||||
| 2024-09-30 | 2024-09-26 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures SPV I, L.P. | JANX | Common Stock | I | 46,7800 | -50.539 | -2.364 | 2.970.875 | ||||
| 2024-09-30 | 2024-09-26 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures I, LP | JANX | Common Stock | I | 46,7800 | -9.592 | -449 | 563.635 | ||||
| 2024-09-30 | 2024-09-26 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 46,7800 | -49.497 | -2.315 | 2.909.678 | ||||
| 2024-09-27 | 2024-09-27 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 45,9551 | -50.000 | -2.298 | 67.592 | ||||
| 2024-09-27 | 2024-09-27 | 4 | Meyer Andrew Hollman | JANX | Common Stock | D | 4,2100 | 50.000 | 210 | 117.592 | ||||
| 2024-09-27 | 2024-09-27 | 4 | Campbell David Alan | JANX | Common Stock | D | 47,8384 | -795 | -38 | 307.054 | ||||
| 2024-09-27 | 2024-09-27 | 4 | Campbell David Alan | JANX | Common Stock | D | 46,8550 | -5.248 | -246 | 307.849 | ||||
| 2024-09-27 | 2024-09-27 | 4 | Campbell David Alan | JANX | Common Stock | D | 46,0893 | -18.957 | -874 | 313.097 | ||||
| 2024-09-27 | 2024-09-27 | 4 | DiRaimondo Thomas | JANX | Common Stock | D | 47,2245 | -675 | -32 | 97.938 | ||||
| 2024-09-27 | 2024-09-27 | 4 | DiRaimondo Thomas | JANX | Common Stock | D | 46,2057 | -4.325 | -200 | 98.613 | ||||
| 2024-09-12 | 2024-09-12 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures SPV I, LP | JANX | Common Stock | I | 47,0000 | -161.356 | -7.584 | 3.021.414 | ||||
| 2024-09-12 | 2024-09-12 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures I, LP | JANX | Common Stock | I | 47,0000 | -30.613 | -1.439 | 573.227 | ||||
| 2024-09-12 | 2024-09-12 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 47,0000 | -158.031 | -7.427 | 2.959.175 | ||||
| 2024-09-12 | 2024-09-10 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures SPV I, LP | JANX | Common Stock | I | 46,6600 | -35.047 | -1.635 | 3.182.770 | ||||
| 2024-09-12 | 2024-09-10 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures I, LP | JANX | Common Stock | I | 46,6600 | -6.649 | -310 | 603.840 | ||||
| 2024-09-12 | 2024-09-10 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 46,6600 | -34.326 | -1.602 | 3.117.206 | ||||
| 2024-09-12 | 2024-09-10 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures SPV I, L.P. | JANX | Common Stock | I | 46,1300 | -11.557 | -533 | 3.217.817 | ||||
| 2024-09-12 | 2024-09-10 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures I, LP | JANX | Common Stock | I | 46,1300 | -2.193 | -101 | 610.489 | ||||
| 2024-09-12 | 2024-09-10 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 46,1300 | -11.319 | -522 | 3.151.532 | ||||
| 2024-09-10 | 2024-09-09 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 42,3300 | -2.182 | -92 | 7.000 | ||||
| 2024-09-10 | 2024-09-09 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 39,8000 | 277 | 11 | 9.182 | ||||
| 2024-09-10 | 2024-09-09 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 13,2200 | 414 | 5 | 8.905 | ||||
| 2024-09-10 | 2024-09-09 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 10,7300 | 414 | 4 | 8.491 | ||||
| 2024-09-10 | 2024-09-09 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 17,0000 | 994 | 17 | 8.077 | ||||
| 2024-09-10 | 2024-09-06 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures SPV I, L.P. | JANX | Common Stock | I | 42,0000 | -110.644 | -4.647 | 3.229.374 | ||||
| 2024-09-10 | 2024-09-06 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures I, LP | JANX | Common Stock | I | 42,0000 | -20.991 | -882 | 612.682 | ||||
| 2024-09-10 | 2024-09-06 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 42,0000 | -108.365 | -4.551 | 3.162.851 | ||||
| 2024-07-24 | 2024-07-19 | 4/A | Hernday Natasha | JANX | Common Stock | D | 1.231 | 6.231 | ||||||
| 2024-07-24 | 2024-07-19 | 4/A | DOBMEIER ERIC | JANX | Common Stock | D | 1.231 | 6.231 | ||||||
| 2024-07-22 | 2024-07-19 | 4 | DOBMEIER ERIC | JANX | Common Stock | D | 2.500 | 7.500 | ||||||
| 2024-07-22 | 2024-07-19 | 4 | DOBMEIER ERIC | JANX | Common Stock | D | 5.000 | 5.000 | ||||||
| 2024-07-22 | 2024-07-19 | 4 | Hernday Natasha | JANX | Common Stock | D | 2.500 | 7.500 | ||||||
| 2024-07-22 | 2024-07-19 | 4 | Hernday Natasha | JANX | Common Stock | D | 5.000 | 5.000 | ||||||
| 2024-06-28 | 2024-06-26 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Common Stock | I | 2.500 | 2.500 | ||||||
| 2024-06-28 | 2024-06-26 | 4 | Gujrathi Sheila | JANX | Common Stock | D | 2.500 | 110.528 | ||||||
| 2024-06-28 | 2024-06-26 | 4 | CAPPS VICKIE L | JANX | Common Stock | D | 2.500 | 68.043 | ||||||
| 2024-06-28 | 2024-06-26 | 4 | Simson Jake | JANX | Common Stock | D | 2.500 | 2.500 | ||||||
| 2024-06-28 | 2024-06-26 | 4 | Barrett Ronald W | JANX | Common Stock | D | 2.500 | 2.500 | ||||||
| 2024-06-28 | 2024-06-26 | 4 | Kung Winston | JANX | Common Stock | D | 2.500 | 2.500 | ||||||
| 2024-06-28 | 2024-06-26 | 4 | McNulty Alana B. | JANX | Common Stock | D | 2.500 | 2.500 | ||||||
| 2024-06-28 | 2024-06-26 | 4 | Lichter Jay | JANX | Common Stock | D | 2.500 | 7.083 | ||||||
| 2024-06-05 | 2024-06-03 | 4 | Lichter Jay By Avalon BioVentures SPV I, L.P. | JANX | Common Stock | I | 54,7500 | -691.525 | -37.861 | 3.340.018 | ||||
| 2024-06-05 | 2024-06-03 | 4 | Lichter Jay By Avalon BioVentures I, LP | JANX | Common Stock | I | 54,7500 | -131.196 | -7.183 | 633.673 | ||||
| 2024-06-05 | 2024-06-03 | 4 | Lichter Jay By Avalon Ventures XI, L.P. | JANX | Common Stock | I | 54,7500 | -677.279 | -37.081 | 3.271.216 | ||||
| 2024-06-05 | 2024-06-03 | 4 | Reardon Tighe By Avalon BioVentures SPV I, L.P. | JANX | Common Stock | I | 54,7500 | -691.525 | -37.861 | 3.340.018 | ||||
| 2024-06-05 | 2024-06-03 | 4 | Reardon Tighe By Avalon BioVentures I, LP | JANX | Common Stock | I | 54,7500 | -131.196 | -7.183 | 633.673 | ||||
| 2024-06-05 | 2024-06-03 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures SPV I, L.P. | JANX | Common Stock | I | 54,7500 | -691.525 | -37.861 | 3.340.018 | ||||
| 2024-06-05 | 2024-06-03 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures I, LP | JANX | Common Stock | I | 54,7500 | -131.196 | -7.183 | 633.673 | ||||
| 2024-06-05 | 2024-06-03 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 54,7500 | -677.279 | -37.081 | 3.271.216 | ||||
| 2024-03-04 | 2024-02-29 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures GP LLC | JANX | Common Stock | I | -1.700 | 0 | ||||||
| 2024-03-04 | 2024-02-29 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures GP LLC | JANX | Common Stock | I | 1.700 | 1.700 | ||||||
| 2024-03-04 | 2024-02-29 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures I, LP | JANX | Common Stock | I | -84.985 | 764.869 | ||||||
| 2024-03-04 | 2024-02-29 | 4 | Avalon Ventures XI, L.P. By ABV SPV I GP LLC | JANX | Common Stock | I | -31.456 | 0 | ||||||
| 2024-03-04 | 2024-02-29 | 4 | Avalon Ventures XI, L.P. By ABV SPV I GP LLC | JANX | Common Stock | I | 31.456 | 31.456 | ||||||
| 2024-03-04 | 2024-02-29 | 4 | Avalon Ventures XI, L.P. By Avalon BioVentures SPV I, LP | JANX | Common Stock | I | -447.949 | 4.031.543 | ||||||
| 2024-03-04 | 2024-02-29 | 4 | Avalon Ventures XI, L.P. By Avalon Ventures XI GP LLC | JANX | Common Stock | I | -11.388 | 0 | ||||||
| 2024-03-04 | 2024-02-29 | 4 | Avalon Ventures XI, L.P. By Avalon Ventures XI GP LLC | JANX | Common Stock | I | 11.388 | 11.388 | ||||||
| 2024-03-04 | 2024-02-29 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | -438.722 | 3.948.495 | ||||||
| 2024-03-04 | 2024-02-29 | 4 | Gujrathi Sheila | JANX | Common Stock | D | 2.986 | 108.028 | ||||||
| 2024-03-04 | 2024-02-29 | 4 | CAPPS VICKIE L | JANX | Common Stock | D | 1.493 | 65.543 | ||||||
| 2024-01-03 | 3 | DiRaimondo Thomas | JANX | Common Stock | D | 101.532 | ||||||||
| 2023-11-15 | 2023-11-13 | 4 | Reardon Tighe | JANX | Common Stock | I | 5,8700 | 849.854 | 4.989 | 849.854 | ||||
| 2023-11-15 | 2023-11-13 | 4 | Lichter Jay | JANX | Common Stock | I | 5,8700 | 849.854 | 4.989 | 849.854 | ||||
| 2023-11-13 | 2023-11-13 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | I | 5,8700 | 849.854 | 4.989 | 849.854 | ||||
| 2023-07-21 | 2023-07-19 | 4 | RA CAPITAL MANAGEMENT, LLC See Footnotes | JANX | Common Stock | I | 12,4600 | 495.008 | 6.168 | 8.117.246 | ||||
| 2022-03-03 | 2022-03-01 | 4 | Robinson Byron | JANX | Stock Option (right to buy) | D | 16,81 | 230.000 | 230.000 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Salek-Ardakani Shahram | JANX | Stock Option (right to buy) | D | 20,24 | 114.250 | 114.250 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Reardon Tighe | JANX | Stock Option (right to buy) | D | 20,24 | 116.750 | 116.750 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Meyer Andrew Hollman | JANX | Stock Option (right to buy) | D | 20,24 | 106.750 | 106.750 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Godfrey Wayne | JANX | Stock Option (right to buy) | D | 20,24 | 114.250 | 114.250 | |||||
| 2022-01-05 | 2022-01-03 | 4 | Campbell David Alan | JANX | Stock Option (right to buy) | D | 20,24 | 354.250 | 354.250 | |||||
| 2021-12-30 | 2021-12-29 | 4 | ORBIMED ADVISORS LLC See Footnotes | JANX | Common Stock | I | 20,3000 | -3.700 | -75 | 231.098 | ||||
| 2021-12-30 | 2021-12-29 | 4 | ORBIMED ADVISORS LLC See Footnotes | JANX | Common Stock | I | 20,3000 | -36.700 | -745 | 2.258.566 | ||||
| 2021-12-30 | 2021-12-29 | 4 | Thompson Peter A. See Footnotes | JANX | Common Stock | I | 20,3000 | -3.700 | -75 | 231.098 | ||||
| 2021-12-30 | 2021-12-29 | 4 | Thompson Peter A. See Footnotes | JANX | Common Stock | I | 20,3000 | -36.700 | -745 | 2.258.566 | ||||
| 2021-12-23 | 2021-12-21 | 4 | ORBIMED ADVISORS LLC See Footnotes | JANX | Common Stock | I | 19,0000 | -11.100 | -211 | 234.798 | ||||
| 2021-12-23 | 2021-12-21 | 4 | ORBIMED ADVISORS LLC See Footnotes | JANX | Common Stock | I | 19,0000 | -108.300 | -2.058 | 2.295.266 | ||||
| 2021-12-23 | 2021-12-21 | 4 | Thompson Peter A. See Footnotes | JANX | Common Stock | I | 19,0000 | -11.100 | -211 | 234.798 | ||||
| 2021-12-23 | 2021-12-21 | 4 | Thompson Peter A. See Footnotes | JANX | Common Stock | I | 19,0000 | -108.300 | -2.058 | 2.295.266 | ||||
| 2021-12-17 | 2021-12-16 | 4 | Thompson Peter A. See Footnotes | JANX | Common Stock | I | 19,0700 | -36.500 | -696 | 245.898 | ||||
| 2021-12-17 | 2021-12-16 | 4 | Thompson Peter A. See Footnotes | JANX | Common Stock | I | 19,0700 | -356.800 | -6.804 | 2.403.566 | ||||
| 2021-12-17 | 2021-12-16 | 4 | ORBIMED ADVISORS LLC See Footnotes | JANX | Common Stock | I | 19,0700 | -36.500 | -696 | 245.898 | ||||
| 2021-12-17 | 2021-12-16 | 4 | ORBIMED ADVISORS LLC See Footnotes | JANX | Common Stock | I | 19,0700 | -356.800 | -6.804 | 2.403.566 | ||||
| 2021-09-09 | 2021-09-07 | 4 | McNulty Alana B. | JANX | Stock Option (right to buy) | D | 29,58 | 30.000 | 30.000 | |||||
| 2021-09-09 | 2021-09-07 | 4 | Barrett Ronald W | JANX | Stock Option (right to buy) | D | 29,58 | 30.000 | 30.000 | |||||
| 2021-06-16 | 2021-06-15 | 4 | Bregua Corp | JANX | Series B Convertible Preferred Stock | D | -192.914 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Bregua Corp | JANX | Series A Convertible Preferred Stock | D | -526.316 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Bregua Corp | JANX | Series Seed 2 Convertible Preferred Stock | D | -1.272.778 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Bregua Corp | JANX | Series Seed Convertible Preferred Stock | D | -888.888 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Bregua Corp | JANX | Common Stock | D | 17,0000 | 58.823 | 1.000 | 3.749.250 | ||||
| 2021-06-16 | 2021-06-15 | 4 | Bregua Corp | JANX | Common Stock | D | 247.123 | 3.690.427 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Bregua Corp | JANX | Common Stock | D | 674.211 | 3.443.304 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Bregua Corp | JANX | Common Stock | D | 1.630.428 | 2.769.093 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Bregua Corp | JANX | Common Stock | D | 1.138.665 | 1.138.665 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Thompson Peter A. See footnotes | JANX | Series B Convertible Preferred Stock | I | -128.609 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Thompson Peter A. See footnotes | JANX | Series B Convertible Preferred Stock | I | -643.046 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Thompson Peter A. See footnotes | JANX | Series A Convertible Preferred Stock | I | -1.052.632 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Thompson Peter A. See footnotes | JANX | Common Stock | I | 17,0000 | 117.650 | 2.000 | 282.398 | ||||
| 2021-06-16 | 2021-06-15 | 4 | Thompson Peter A. See footnotes | JANX | Common Stock | I | 164.748 | 164.748 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Thompson Peter A. See footnotes | JANX | Common Stock | I | 17,0000 | 588.203 | 9.999 | 2.760.366 | ||||
| 2021-06-16 | 2021-06-15 | 4 | Thompson Peter A. See footnotes | JANX | Common Stock | I | 823.742 | 2.172.163 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Thompson Peter A. See footnotes | JANX | Common Stock | I | 1.348.421 | 1.348.421 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | ORBIMED ADVISORS LLC See footnotes | JANX | Series B Convertible Preferred Stock | I | -128.609 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | ORBIMED ADVISORS LLC See footnotes | JANX | Series B Convertible Preferred Stock | I | -643.046 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | ORBIMED ADVISORS LLC See footnotes | JANX | Series A Convertible Preferred Stock | I | -1.052.632 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | ORBIMED ADVISORS LLC See footnotes | JANX | Common Stock | I | 17,0000 | 117.650 | 2.000 | 282.398 | ||||
| 2021-06-16 | 2021-06-15 | 4 | ORBIMED ADVISORS LLC See footnotes | JANX | Common Stock | I | 164.748 | 164.748 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | ORBIMED ADVISORS LLC See footnotes | JANX | Common Stock | I | 17,0000 | 588.203 | 9.999 | 2.760.366 | ||||
| 2021-06-16 | 2021-06-15 | 4 | ORBIMED ADVISORS LLC See footnotes | JANX | Common Stock | I | 823.742 | 2.172.163 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | ORBIMED ADVISORS LLC See footnotes | JANX | Common Stock | I | 1.348.421 | 1.348.421 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Reardon Tighe | JANX | Series B Convertible Preferred Stock | I | -900.264 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Reardon Tighe | JANX | Series A Convertible Preferred Stock | I | -2.105.264 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Reardon Tighe | JANX | Common Stock | I | 17,0000 | 629.411 | 10.700 | 4.479.492 | ||||
| 2021-06-16 | 2021-06-15 | 4 | Reardon Tighe | JANX | Common Stock | I | 1.153.238 | 3.850.081 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Reardon Tighe | JANX | Common Stock | I | 2.696.843 | 2.696.843 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Lichter Jay | JANX | Series B Convertible Preferred Stock | I | -900.264 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Lichter Jay | JANX | Series A Convertible Preferred Stock | I | -2.105.264 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Lichter Jay | JANX | Series A Convertible Preferred Stock | I | -526.316 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Lichter Jay | JANX | Series Seed 2 Convertible Preferred Stock | I | -1.859.634 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Lichter Jay | JANX | Series Seed Convertible Preferred Stock | I | -888.888 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Lichter Jay | JANX | Common Stock | I | 17,0000 | 629.411 | 10.700 | 4.479.492 | ||||
| 2021-06-16 | 2021-06-15 | 4 | Lichter Jay | JANX | Common Stock | I | 1.153.238 | 3.850.081 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Lichter Jay | JANX | Common Stock | I | 2.696.843 | 2.696.843 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Lichter Jay | JANX | Common Stock | I | 674.211 | 4.387.217 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Lichter Jay | JANX | Common Stock | I | 2.382.191 | 3.713.006 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Lichter Jay | JANX | Common Stock | I | 1.138.665 | 1.330.815 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Avalon Ventures XI, L.P. | JANX | Series B Convertible Preferred Stock | I | -900.264 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Avalon Ventures XI, L.P. | JANX | Series A Convertible Preferred Stock | I | -2.105.264 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Avalon Ventures XI, L.P. | JANX | Series A Convertible Preferred Stock | D | -526.316 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Avalon Ventures XI, L.P. | JANX | Series Seed 2 Convertible Preferred Stock | D | -1.859.634 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Avalon Ventures XI, L.P. | JANX | Series Seed Convertible Preferred Stock | D | -888.888 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | I | 17,0000 | 629.411 | 10.700 | 4.479.492 | ||||
| 2021-06-16 | 2021-06-15 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | I | 1.153.238 | 3.850.081 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | I | 2.696.843 | 2.696.843 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 674.211 | 4.387.217 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 2.382.191 | 3.713.006 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | Avalon Ventures XI, L.P. | JANX | Common Stock | D | 1.138.665 | 1.330.815 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Series A Convertible Preferred Stock | I | -434.056 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Series A Convertible Preferred Stock | I | -2.459.649 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Series A Convertible Preferred Stock | I | -236.842 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Series A Convertible Preferred Stock | I | -1.342.106 | 0 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Common Stock | I | 17,0000 | 188.986 | 3.213 | 1.048.406 | ||||
| 2021-06-16 | 2021-06-15 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Common Stock | I | 556.026 | 859.420 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Common Stock | I | 303.394 | 303.394 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Common Stock | I | 17,0000 | 2.752.190 | 46.787 | 7.622.238 | ||||
| 2021-06-16 | 2021-06-15 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Common Stock | I | 3.150.810 | 4.870.048 | ||||||
| 2021-06-16 | 2021-06-15 | 4 | RA CAPITAL MANAGEMENT, LLC See footnotes | JANX | Common Stock | I | 1.719.238 | 1.719.238 | ||||||
| 2021-06-14 | 2021-06-10 | 4 | Thompson Peter A. | JANX | Stock Option (right to buy) | D | 17,00 | 30.000 | 30.000 | |||||
| 2021-06-14 | 2021-06-10 | 4 | Simson Jake | JANX | Stock Option (right to buy) | D | 17,00 | 30.000 | 30.000 | |||||
| 2021-06-14 | 2021-06-10 | 4 | Lichter Jay | JANX | Stock Option (right to buy) | D | 17,00 | 30.000 | 30.000 | |||||
| 2021-06-10 | 3 | Avalon BioVentures SPV I, L.P. | JANX | Common Stock | D | 192.150 | ||||||||
| 2021-06-10 | 3 | Reardon Tighe | JANX | Common Stock | D | 172.935 | ||||||||
| 2021-06-10 | 3 | Meyer Andrew Hollman | JANX | Common Stock | D | 59.416 | ||||||||
| 2021-06-10 | 3 | Lichter Jay | JANX | Common Stock | I | 192.150 | ||||||||
| 2021-06-10 | 3 | Heller Stefan | JANX | Common Stock | D | 96.075 | ||||||||
| 2021-06-10 | 3 | Gujrathi Sheila | JANX | Common Stock | D | 105.042 | ||||||||
| 2021-06-10 | 3 | CAPPS VICKIE L | JANX | Common Stock | D | 64.050 | ||||||||
| 2021-06-10 | 3 | Campbell David Alan | JANX | Common Stock | D | 332.054 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
